Farrell Michael J. 4
4 · RESMED INC · Filed Nov 26, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Farrell Michael J.
DirectorChairman and CEO
Transactions
- Award
ResMed Common Stock Options
2025-11-24$250.52/sh+33,288$8,339,310→ 33,288 totalExercise: $250.52From: 2026-11-11Exp: 2032-11-11→ ResMed Common Stock (33,288 underlying)
Holdings
- 466,223
ResMed Common Stock
Footnotes (1)
- [F1]Represents the date on which options first become exercisable. The options vest in three equal annual installments commencing on November 11, 2026.